- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Patent holdings for IPC class A61P 29/00
Total number of patents in this class: 20128
10-year publication summary
742
|
805
|
755
|
1158
|
1391
|
1513
|
1584
|
1699
|
1587
|
452
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
F. Hoffmann-La Roche AG | 7958 |
205 |
Boehringer Ingelheim International GmbH | 4629 |
195 |
Bristol-myers Squibb Company | 5080 |
182 |
Janssen Pharmaceutica N.V. | 3839 |
175 |
Novartis AG | 11238 |
159 |
Takeda Pharmaceutical Company Limited | 2961 |
157 |
Allergan, Inc. | 2600 |
115 |
AstraZeneca AB | 3042 |
113 |
Daiichi Sankyo Company, Limited | 1829 |
94 |
The Regents of the University of California | 18943 |
93 |
Grünenthal GmbH | 625 |
93 |
Glaxo Group Limited | 4496 |
90 |
Amgen Inc. | 3779 |
89 |
Genentech, Inc. | 3742 |
86 |
Merck Patent GmbH | 5909 |
84 |
Vertex Pharmaceuticals Incorporated | 1581 |
81 |
Centre National de La Recherche Scientifique | 9632 |
79 |
Gilead Sciences, Inc. | 1879 |
71 |
Hoffmann-La Roche Inc. | 3060 |
70 |
Jiangsu Hengrui Medicine Co., Ltd. | 780 |
68 |
Other owners | 17829 |